N-Acetylcysteine Dosing for Endometriosis
For symptomatic endometriosis in reproductive-age women, administer oral N-acetylcysteine 600 mg three times daily for 3 consecutive days per week, repeated quarterly for at least 3 months, as an adjunct to—not a replacement for—standard hormonal or surgical therapy.
Guideline Framework
ACOG explicitly states that dietary supplements, including NAC, are not included as standard primary treatments for endometriosis and should not replace established medical therapy (progestins, oral contraceptives, NSAIDs, GnRH agonists, or danazol) 1. Standard hormonal or surgical therapy must remain the primary treatment approach 1.
Evidence-Based NAC Dosing Protocol
The most robust clinical evidence supports the following regimen:
- 600 mg oral NAC, 3 tablets per day (total 1800 mg/day)
- Administered for 3 consecutive days each week
- Duration: 3 months minimum 2
This intermittent dosing schedule (3 days on, 4 days off weekly) demonstrated significant clinical benefits in a prospective study of 120 patients 2.
Alternative Continuous Dosing
Some evidence supports continuous daily dosing:
- 1200 mg/day (divided dosing) showed benefits in reducing apoptosis in granulosa cells and improving oxidative stress markers in infertile women with endometriosis 3
- 150 mg/day as part of a combination supplement (with quercetin and curcumin) reduced pain symptoms, though this lower dose was not NAC monotherapy 4
Clinical Outcomes with Recommended Dosing
The 600 mg three-times-daily intermittent regimen (3 days/week for 3 months) demonstrated:
- Significant reduction in dysmenorrhea, dyspareunia, and chronic pelvic pain (p < 0.0001) 2
- Decreased endometrioma size (p < 0.0001) 2
- Reduced NSAID consumption (p = 0.001) 2
- Decreased CA-125 serum levels (p < 0.0001) 2
- Improved pregnancy rates: 75% of patients with reproductive desire (39/52) achieved pregnancy within 6 months of starting therapy (p = 0.001) 2
Critical Implementation Points
Monitor clinical response including symptom relief and tolerability, adjusting the regimen as needed 1. NAC functions as an adjunctive intervention only—continue standard hormonal therapy concurrently 1.
No fertility harm: Current evidence does not demonstrate that NAC affects future fertility negatively in women with endometriosis 1. In fact, the antioxidant properties may improve fertility outcomes by reducing oxidative stress and apoptosis in granulosa cells 3.
Common Pitfalls to Avoid
- Never discontinue standard medical therapy to use NAC alone—this violates guideline-based care and may worsen morbidity 1
- Do not use FDA-labeled acetylcysteine dosing (designed for acetaminophen overdose or mucolytic therapy) for endometriosis—these are entirely different indications 5
- Avoid expecting complete lesion eradication—no medical therapy, including NAC, has been shown to completely eliminate endometriosis lesions 1
Practical Algorithm
- Confirm endometriosis diagnosis and initiate/continue standard hormonal or surgical therapy 1
- Add NAC 600 mg orally, 3 tablets daily for 3 consecutive days per week 2
- Reassess at 3 months: evaluate pain scores (VAS), NSAID use, and if applicable, endometrioma size via transvaginal ultrasound 2
- Continue if beneficial; consider quarterly cycles for sustained symptom control 2